Cargando…

Corrigendum: Receptor of advanced glycation end products deficiency attenuates cisplatin-induced acute nephrotoxicity by inhibiting apoptosis, inflammation and restoring fatty acid oxidation

Detalles Bibliográficos
Autores principales: Wang, Qiang, Xi, Yuemei, Chen, Binyang, Zhao, Hairong, Yu, Wei, Xie, De, Liu, Weidong, He, Furong, Xu, Chenxi, Cheng, Jidong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664383/
https://www.ncbi.nlm.nih.gov/pubmed/36386170
http://dx.doi.org/10.3389/fphar.2022.1022539
_version_ 1784831088368025600
author Wang, Qiang
Xi, Yuemei
Chen, Binyang
Zhao, Hairong
Yu, Wei
Xie, De
Liu, Weidong
He, Furong
Xu, Chenxi
Cheng, Jidong
author_facet Wang, Qiang
Xi, Yuemei
Chen, Binyang
Zhao, Hairong
Yu, Wei
Xie, De
Liu, Weidong
He, Furong
Xu, Chenxi
Cheng, Jidong
author_sort Wang, Qiang
collection PubMed
description
format Online
Article
Text
id pubmed-9664383
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96643832022-11-15 Corrigendum: Receptor of advanced glycation end products deficiency attenuates cisplatin-induced acute nephrotoxicity by inhibiting apoptosis, inflammation and restoring fatty acid oxidation Wang, Qiang Xi, Yuemei Chen, Binyang Zhao, Hairong Yu, Wei Xie, De Liu, Weidong He, Furong Xu, Chenxi Cheng, Jidong Front Pharmacol Pharmacology Frontiers Media S.A. 2022-11-01 /pmc/articles/PMC9664383/ /pubmed/36386170 http://dx.doi.org/10.3389/fphar.2022.1022539 Text en Copyright © 2022 Wang, Xi, Chen, Zhao, Yu, Xie, Liu, He, Xu and Cheng. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Wang, Qiang
Xi, Yuemei
Chen, Binyang
Zhao, Hairong
Yu, Wei
Xie, De
Liu, Weidong
He, Furong
Xu, Chenxi
Cheng, Jidong
Corrigendum: Receptor of advanced glycation end products deficiency attenuates cisplatin-induced acute nephrotoxicity by inhibiting apoptosis, inflammation and restoring fatty acid oxidation
title Corrigendum: Receptor of advanced glycation end products deficiency attenuates cisplatin-induced acute nephrotoxicity by inhibiting apoptosis, inflammation and restoring fatty acid oxidation
title_full Corrigendum: Receptor of advanced glycation end products deficiency attenuates cisplatin-induced acute nephrotoxicity by inhibiting apoptosis, inflammation and restoring fatty acid oxidation
title_fullStr Corrigendum: Receptor of advanced glycation end products deficiency attenuates cisplatin-induced acute nephrotoxicity by inhibiting apoptosis, inflammation and restoring fatty acid oxidation
title_full_unstemmed Corrigendum: Receptor of advanced glycation end products deficiency attenuates cisplatin-induced acute nephrotoxicity by inhibiting apoptosis, inflammation and restoring fatty acid oxidation
title_short Corrigendum: Receptor of advanced glycation end products deficiency attenuates cisplatin-induced acute nephrotoxicity by inhibiting apoptosis, inflammation and restoring fatty acid oxidation
title_sort corrigendum: receptor of advanced glycation end products deficiency attenuates cisplatin-induced acute nephrotoxicity by inhibiting apoptosis, inflammation and restoring fatty acid oxidation
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664383/
https://www.ncbi.nlm.nih.gov/pubmed/36386170
http://dx.doi.org/10.3389/fphar.2022.1022539
work_keys_str_mv AT wangqiang corrigendumreceptorofadvancedglycationendproductsdeficiencyattenuatescisplatininducedacutenephrotoxicitybyinhibitingapoptosisinflammationandrestoringfattyacidoxidation
AT xiyuemei corrigendumreceptorofadvancedglycationendproductsdeficiencyattenuatescisplatininducedacutenephrotoxicitybyinhibitingapoptosisinflammationandrestoringfattyacidoxidation
AT chenbinyang corrigendumreceptorofadvancedglycationendproductsdeficiencyattenuatescisplatininducedacutenephrotoxicitybyinhibitingapoptosisinflammationandrestoringfattyacidoxidation
AT zhaohairong corrigendumreceptorofadvancedglycationendproductsdeficiencyattenuatescisplatininducedacutenephrotoxicitybyinhibitingapoptosisinflammationandrestoringfattyacidoxidation
AT yuwei corrigendumreceptorofadvancedglycationendproductsdeficiencyattenuatescisplatininducedacutenephrotoxicitybyinhibitingapoptosisinflammationandrestoringfattyacidoxidation
AT xiede corrigendumreceptorofadvancedglycationendproductsdeficiencyattenuatescisplatininducedacutenephrotoxicitybyinhibitingapoptosisinflammationandrestoringfattyacidoxidation
AT liuweidong corrigendumreceptorofadvancedglycationendproductsdeficiencyattenuatescisplatininducedacutenephrotoxicitybyinhibitingapoptosisinflammationandrestoringfattyacidoxidation
AT hefurong corrigendumreceptorofadvancedglycationendproductsdeficiencyattenuatescisplatininducedacutenephrotoxicitybyinhibitingapoptosisinflammationandrestoringfattyacidoxidation
AT xuchenxi corrigendumreceptorofadvancedglycationendproductsdeficiencyattenuatescisplatininducedacutenephrotoxicitybyinhibitingapoptosisinflammationandrestoringfattyacidoxidation
AT chengjidong corrigendumreceptorofadvancedglycationendproductsdeficiencyattenuatescisplatininducedacutenephrotoxicitybyinhibitingapoptosisinflammationandrestoringfattyacidoxidation